FDA Expands Indications for MED-EL Cochlear Implants, Approves Hearing Preservation Claims
The FDA has broadened the indications for MED-EL cochlear implants, allowing more adults with moderate-to-profound sensorineural hearing loss to qualify for the device.
MED-EL Cochlear Implant System Receives FDA Approval for Expanded Indications and Hearing Preservation
The FDA has approved expanded indications for the MED-EL Cochlear Implant System, allowing more adults with bilateral moderate-to-profound sensorineural hearing loss to qualify.
MED-EL Cochlear Implant Receives FDA Approval for Expanded Indications and Hearing Preservation Claims
MED-EL's cochlear implant system secures FDA approval for expanded use in adults with moderate-to-profound sensorineural hearing loss, setting a new industry standard.
© Copyright 2025. All Rights Reserved by MedPath